Detailed SMPC and OD register data for: Adzynma
Data as extracted from Orphan Designation Register
Product (OD)
Adzynma
PL number (OD)
PL 16189/0148
OD Designation ID (OD)
OD1
Active substance (OD)
recombinant human A disintegrin and metalloproteinase with thrombospondin motifs 13 (rADAMTS13)
Data as extracted from SMPC. (PS: More information at bottom of the page)
Product (SMPC)
PL Number (SMPC)
Composition/ Active Substance (SMPC)
Dose form (SMPC)
Marketing Authorisation holder details (SMPC)
AI match to EMA Substance Dictionary
We analysed the SMPC composition text and searched for the closest equivalent in EMA's published substance dictionary. The suggested match and supporting details are shown below.
SMPC composition / active substance
Matched EMA substance
EMA SMS ID
Confidence
Higher confidence means the match is more likely to be correct.
Show AI rationale
Further information for:
Select a section below to read the detailed content extracted from the SMPC / Orphan Designation register.
OD Indication (OD)
Adzynma as an enzyme replacement therapy indicated for the treatment of ADAMTS13 deficiency in children and adult patients with congenital thrombotic thrombocytopenic purpura of all age groups
Full Designation Number(OD)
PL 16189/0148-0149/OD1
Orphan Condition(OD)
Thrombotic thrombocytopenic purpura (TTP)
All Indications (SMPC)
All Contraindications (SMPC)
Warnings/Precautions (SMPC)
Interactions (SMPC)
Pregnancy/Lactation (SMPC)
Driving/Machines (SMPC)
Undesirable effects (SMPC)
Overdose (SMPC)
Shelf life (SMPC)
Storage (SMPC)
Container description (SMPC)
Handling/Disposal (SMPC)
SMPC_URL